PHARMA PARTNER AS

3046 DRAMMEN

Finances

Return on Equity

11,41 %

Current Ratio

1,65

Debt-to-Equity Ratio

0,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	927 000	3 179 000	5 129 000	2 094 000
Net Income	43 000	335 000	821 000	431 000
Total Assets	571 000	1 959 000	2 602 000	800 000
Total Equity	377 000	334 000	399 000	−91 000

Income (NOK)	2022	2021	2020	2019
Revenue	927 000	3 179 000	5 129 000	2 094 000
Expenditure	874 000	2 737 000	4 343 000	1 866 000
Operating Profit	52 000	442 000	786 000	227 000
Financial Income	1 000	3 000	171 000	211 000
Financial Costs	−3 000	11 000	60 000	7 000
Financial Balance	4 000	−8 000	111 000	204 000
Earnings Before Tax	56 000	433 000	896 000	431 000
Tax	14 000	99 000	76 000	0
Net Income	43 000	335 000	821 000	431 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	252 000	81 000	42 000	34 000
Total Current Assets	319 000	1 878 000	2 561 000	766 000
Total Assets	571 000	1 959 000	2 602 000	800 000
Total Retained Equity	277 000	234 000	299 000	−191 000
Total Equity	377 000	334 000	399 000	−91 000
Total Long-Term Debt	2 000	4 000	3 000	0
Total Current Debt	193 000	1 621 000	2 200 000	891 000
Total Equity and Debt	571 000	1 959 000	2 602 000	800 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	927 000	3 441 000	3 371 000	2 094 000
Other Income	0	−262 000	1 758 000	0
Revenue	927 000	3 179 000	5 129 000	2 094 000
Cost of Goods Sold	55 000	404 000	1 147 000	497 000
Salary Costs	428 000	1 824 000	2 455 000	755 000
Depreciation	10 000	11 000	10 000	7 000
Impairment	0	0	0	0
Expenditure	874 000	2 737 000	4 343 000	1 866 000
Operating Profit	52 000	442 000	786 000	227 000
Financial Income	1 000	3 000	171 000	211 000
Financial Costs	−3 000	11 000	60 000	7 000
Financial Balance	4 000	−8 000	111 000	204 000
Dividends	0	400 000	330 000	0
Net Income	43 000	335 000	821 000	431 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	8 000	19 000	29 000	21 000
Total Tangible Assets	8 000	19 000	29 000	21 000
Total Fiancial Fixed Assets	244 000	62 000	12 000	13 000
Total Fixed Assets	252 000	81 000	42 000	34 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	230 000	684 000	487 000	294 000
Total Current Assets	319 000	1 878 000	2 561 000	766 000
Total Assets	571 000	1 959 000	2 602 000	800 000
Total Equity	377 000	334 000	399 000	−91 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	2 000	4 000	3 000	0
Creditors	37 000	515 000	666 000	105 000
Unpaid Taxes	37 000	438 000	764 000	589 000
Dividends	0	400 000	330 000	0
Other Current Debt	103 000	169 000	367 000	197 000
Total Current Debt	193 000	1 621 000	2 200 000	891 000
Total Equity and Debt	571 000	1 959 000	2 602 000	800 000

Financial indicators	2022	2021	2020	2019
Return on Equity	11,41 %	100,3 %	205,76 %	−473,63 %
Debt-to-Equity Ratio	0,01	0,01	0,01	−0
Operating Profit Margin	5,61 %	13,9 %	15,32 %	10,84 %
Current Ratio	1,65	1,16	1,16	0,86
Quick Ratio	1,65	1,16	1,16	0,86
Equity Ratio	0,66	0,17	0,15	−0,11
Gross Profit Margin	94,07 %	87,29 %	77,64 %	76,27 %